Alliance Expands Social Media Presence to BlueSky, Instagram and Threads
To ensure life-saving cancer research reaches every community that needs it, the Alliance for Clinical Trials in Oncology has expanded our digital footprint beyond Facebook, X (Twitter), LinkedIn, and YouTube. By establishing dedicated presences on Bluesky, Instagram, and Threads, the Alliance is dramatically expanding its reach to help connect with additional investigators, patient advocates and patients.
Here is how moving beyond legacy platforms directly amplifies the network’s reach and impact:
Reaching Younger Audiences and Broadening Patient Populations
Historically, fewer than 5% of adult cancer patients participate in clinical trials, with younger patients, people with less formal education, and rural populations particularly underrepresented.
- Connecting with Young Adults (AYA): Patients in their teens, 20s, and 30s actively seek support and health information on Instagram. Visual carousels and investigator-led Reels allow the Alliance to meet Adolescent and Young Adult (AYA) patients where they already gather.
- Breaking Down Language and Complexity Barriers: Visually driven content transforms complex trial protocols into plain-language infographics, making research approachable and accessible to broader, non-academic audiences.
Eliminating Algorithmic and Scientific Barriers
Ever-changing algorithms and paywalled content on legacy channels often prevent critical medical updates from reaching the new eyes.
- Direct Scientific Connection via Bluesky: By using open feeds like #OncSky, Alliance trial announcements reach oncologists, community physicians, and academic researchers directly, unfiltered by paywalls or algorithmic suppression.
- Engaging the Broader Public on Threads: Threads allows us to embed plain-language clinical trial updates into everyday public health discussions, reaching patients and caregivers who aren't actively searching medical databases.
From Digital Discovery to Trial Enrollment
Expanding reach isn't just about accumulating followers, it’s about building a direct pathway from online discovery to active trial participation:
- Discovery: Bluesky, Instagram, and Threads posts reach new audiences well beyond traditional medical networks.
- Demystification: Visual infographics and videos address trial fears, explain eligibility, and build institutional trust.
- Action: Direct links guide patients and referring physicians straight to local enrollment resources and active trial sites.
By meeting researchers, patients, and caregivers where they already communicate, we can ensure clinical trials and results are more visible, inclusive, and actionable for everyone.
Be sure to follow us on all our platforms:
BlueSky: https://bsky.app/profile/alliance-org.bsky.social
Facebook: https://www.facebook.com/AllianceForClinicalTrialsInOncology/
Instagram: https://www.instagram.com/allianceforclinicaltrials/
Threads: https://www.threads.com/@allianceforclinicaltrials
Twitter/X: https://x.com/ALLIANCE_org
YouTube: https://www.youtube.com/@TheAllianceTraining
